title: Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol.
abstract: Various beta-blockers possessing similar antihypertensive potency have been found to differ widely with regard to their influence on blood pressure-regulating factors such as cardiac output and plasma levels of renin or norepinephrine. Recently, beta-blocker-induced stimulation of circulating atrial natriuretic factor (ANF) was reported. Blood pressure is determined not only by levels of vasoconstrictive factors but also by tissue reactivity. To investigate these aspects, we assessed the cardiovascular responsiveness to norepinephrine and angiotensin II, plasma levels of catecholamines, angiotensin II, ANF and aldosterone and the body sodium-blood volume state of 15 patients with essential hypertension (mean age +/- s.e.m., 42 +/- 3 years) and 12 normal control subjects (41 +/- 5 years), first on placebo and then after 4 weeks of intervention with carteolol, a non-selective beta-adrenergic antagonist with intrinsic sympathomimetic activity. Compared with placebo, carteolol decreased resting plasma norepinephrine in both groups while plasma norepinephrine-blood pressure response curves were shifted to the left, their slopes increased and norepinephrine pressor doses decreased (P less than 0.05 to less than 0.001). Chronotropic responses to isoproterenol were abolished but negative chronotropic responses to a norepinephrine-induced 20 mmHg rise in diastolic blood pressure were unaltered. Plasma norepinephrine clearance in the supine position was slightly decreased in hypertensive and unchanged in normal subjects. Supine and upright blood pressure was lowered (P less than 0.05 to 0.001) in the hypertensive while upright systolic blood pressure only decreased in the normal group.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Medizinische Poliklinik, University of Bern, Switzerland.
authors.forename: H
authors.initials: H
authors.lastname: Saxenhofer
authors.forename: D
authors.initials: D
authors.lastname: Morger
authors.forename: P
authors.initials: P
authors.lastname: Weidmann
authors.forename: C
authors.initials: C
authors.lastname: Ferrier
authors.forename: S G
authors.initials: SG
authors.lastname: Shaw
mesh_terms: D000328:Adult; D000804:Angiotensin II / Q000502:physiology; D009320:Atrial Natriuretic Factor / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D002354:Carteolol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000502:physiology*; D016037:Single-Blind Method
chemical_list: D011943:Receptors, Adrenergic, beta; D000804:Angiotensin II; D009320:Atrial Natriuretic Factor; D002354:Carteolol; D007545:Isoproterenol; D009638:Norepinephrine